Works by Ogasawara, Sadahisa

Results: 97
    1

    Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients.

    Published in:
    PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0209352
    By:
    • Kumagai, Junichiro;
    • Taida, Takashi;
    • Ogasawara, Sadahisa;
    • Nakagawa, Tomoo;
    • Iino, Yotaro;
    • Shingyoji, Ayako;
    • Ishikawa, Kentaro;
    • Akizue, Naoki;
    • Yamato, Mutsumi;
    • Takahashi, Koji;
    • Ohta, Yuki;
    • Hamanaka, Shinsaku;
    • Okimoto, Kenichiro;
    • Nakamura, Masato;
    • Ohyama, Hiroshi;
    • Saito, Keiko;
    • Kusakabe, Yuko;
    • Maruoka, Daisuke;
    • Yasui, Shin;
    • Matsumura, Tomoaki
    Publication type:
    Article
    2

    Liver cirrhosis is a risk factor for poor prognosis of acute cholangitis caused by choledocholithiasis.

    Published in:
    Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2022, v. 27, n. 3, p. 1, doi. 10.1016/j.aohep.2022.100696
    By:
    • Miyuki Sensui;
    • Shin Yasui;
    • Sadahisa Ogasawara;
    • Hidehiro Kamezaki;
    • Motoyasu Kan;
    • Shikiko Maruta;
    • Toshihito Yamada;
    • Yoshifumi Miura;
    • Kosho Asano;
    • Yukiko Shima;
    • Hiroki Nagashima;
    • Masayuki Yokoyama;
    • Yuko Kusakabe;
    • Harutoshi Sugiyama;
    • Izumi Ohno;
    • Rintaro Mikata;
    • Jun Kato;
    • Toshio Tsuyuguchi;
    • Naoya Kato
    Publication type:
    Article
    3

    Outcomes for Underwater Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection of 21–30-mm Colorectal Polyps: A Feasible Study.

    Published in:
    Digestive Diseases & Sciences, 2023, v. 68, n. 10, p. 3963, doi. 10.1007/s10620-023-08093-y
    By:
    • Okimoto, Kenichiro;
    • Matsumura, Tomoaki;
    • Matsusaka, Keisuke;
    • Inaba, Yosuke;
    • Ishikawa, Tsubasa;
    • Akizue, Naoki;
    • Kaneko, Tatsuya;
    • Ota, Masayuki;
    • Ohta, Yuki;
    • Taida, Takashi;
    • Saito, Keiko;
    • Ogasawara, Sadahisa;
    • Maruoka, Daisuke;
    • Kato, Jun;
    • Ikeda, Jun-ichiro;
    • Kato, Naoya
    Publication type:
    Article
    4
    5

    Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2025, v. 55, n. 5, p. 718, doi. 10.1111/hepr.14160
    By:
    • Yonemoto, Takuya;
    • Ogasawara, Sadahisa;
    • Kanogawa, Naoya;
    • Miwa, Chihiro;
    • Fujiya, Makoto;
    • Tsuchiya, Takahiro;
    • Sawada, Midori;
    • Akatsuka, Teppei;
    • Izai, Ryo;
    • Yumita, Sae;
    • Nakagawa, Miyuki;
    • Okubo, Tomomi;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Itobayashi, Ei
    Publication type:
    Article
    6

    Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage‐associated molecular pattern analysis.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 291, doi. 10.1111/hepr.14088
    By:
    • Ozaki, Tomomi;
    • Yumita, Sae;
    • Ogasawara, Sadahisa;
    • Fujiya, Makoto;
    • Tsuchiya, Takahiro;
    • Yoshino, Ryohei;
    • Sawada, Midori;
    • Akatsuka, Teppei;
    • Izai, Ryo;
    • Miwa, Chihiro;
    • Yonemoto, Takuya;
    • Fujimoto, Kentaro;
    • Unozawa, Hidemi;
    • Fujiwara, Kisako;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Nakamura, Masato
    Publication type:
    Article
    7

    Carbon‐ion radiotherapy versus radiofrequency ablation as initial treatment for early‐stage hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2022, v. 52, n. 12, p. 1060, doi. 10.1111/hepr.13827
    By:
    • Fujita, Naoto;
    • Kanogawa, Naoya;
    • Makishima, Hirokazu;
    • Ogasawara, Sadahisa;
    • Maruta, Susumu;
    • Iino, Yotaro;
    • Shiko, Yuki;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Wakatsuki, Masaru;
    • Itobayashi, Ei;
    • Obu, Masamichi;
    • Koma, Yoshihiro;
    • Azemoto, Ryosaku
    Publication type:
    Article
    8
    9

    "Salvage techniques" are the key to overcome difficult biliary cannulation in endoscopic retrograde cholangiopancreatography.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17809-5
    By:
    • Maruta, Shikiko;
    • Sugiyama, Harutoshi;
    • Ogasawara, Sadahisa;
    • Sugihara, Chihei;
    • Ouchi, Mayu;
    • Kan, Motoyasu;
    • Yamada, Toshihito;
    • Miura, Yoshifumi;
    • Nagashima, Hiroki;
    • Takahashi, Koji;
    • Kusakabe, Yuko;
    • Ohyama, Hiroshi;
    • Okitsu, Koichiro;
    • Ohno, Izumi;
    • Mikata, Rintaro;
    • Sakai, Yuji;
    • Tsuyuguchi, Toshio;
    • Kato, Jun;
    • Kato, Naoya
    Publication type:
    Article
    10

    Phase II study comparing nasal pressure monitoring with capnography during invasive endoscopic procedures: a single-center, single-arm trial.

    Published in:
    Scientific Reports, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28213-y
    By:
    • Nagashima, Hiroki;
    • Mikata, Rintaro;
    • Isono, Shiroh;
    • Ogasawara, Sadahisa;
    • Sugiyama, Harutoshi;
    • Ohno, Izumi;
    • Yasui, Shin;
    • Matsumura, Tomoaki;
    • Koroki, Keisuke;
    • Kusakabe, Yuko;
    • Miura, Yoshifumi;
    • Kan, Motoyasu;
    • Maruta, Shikiko;
    • Yamada, Toshihito;
    • Takemura, Ryo;
    • Sato, Yasunori;
    • Kato, Jun;
    • Kato, Naoya
    Publication type:
    Article
    11

    EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00889-0
    By:
    • Kusakabe, Yuko;
    • Chiba, Tetsuhiro;
    • Oshima, Motohiko;
    • Koide, Shuhei;
    • Rizq, Ola;
    • Aoyama, Kazumasa;
    • Ao, Junjie;
    • Kaneko, Tatsuya;
    • Kanzaki, Hiroaki;
    • Kanayama, Kengo;
    • Maeda, Takahiro;
    • Saito, Tomoko;
    • Nakagawa, Ryo;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Ogasawara, Sadahisa;
    • Suzuki, Eiichiro;
    • Nakamoto, Shingo;
    • Yasui, Shin
    Publication type:
    Article
    12
    13

    Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice.

    Published in:
    BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02731-5
    By:
    • Yumita, Sae;
    • Ogasawara, Sadahisa;
    • Nakagawa, Miyuki;
    • Maruta, Susumu;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Kogure, Tadayoshi;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Fujiwara, Kisako;
    • Iwanaga, Terunao;
    • Fujita, Naoto;
    • Sakuma, Takafumi;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke
    Publication type:
    Article
    14

    Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma.

    Published in:
    BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02674-x
    By:
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Maruta, Susumu;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Yumita, Sae;
    • Iwanaga, Terunao;
    • Unozawa, Hidemi;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Inoue, Masanori;
    • Kiyono, Soichiro
    Publication type:
    Article
    15
    16

    Switching to systemic therapy after locoregional treatment failure: Definition and best timing.

    Published in:
    Clinical & Molecular Hepatology, 2020, v. 26, n. 2, p. 155, doi. 10.3350/cmh.2019.0021n
    By:
    • Sadahisa Ogasawara;
    • Yoshihiko Ooka;
    • Keisuke Koroki;
    • Susumu Maruta;
    • Hiroaki Kanzaki;
    • Kengo Kanayama;
    • Kazufumi Kobayashi;
    • Soichiro Kiyono;
    • Masato Nakamura;
    • Naoya Kanogawa;
    • Tomoko Saito;
    • Takayuki Kondo;
    • Eiichiro Suzuki;
    • Shingo Nakamoto;
    • Akinobu Tawada;
    • Tetsuhiro Chiba;
    • Makoto Arai;
    • Jun Kato;
    • Naoya Kato
    Publication type:
    Article
    17
    18

    Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13648-5
    By:
    • Kodama, Yoshihisa;
    • Ueshima, Kazuomi;
    • Moriguchi, Michihisa;
    • Inaba, Yoshitaka;
    • Yamashita, Tatsuya;
    • Iwamoto, Hideki;
    • Ueno, Makoto;
    • Ogasawara, Sadahisa;
    • Kuzuya, Teiji;
    • Kodama, Takahiro;
    • Sato, Yozo;
    • Tada, Toshifumi;
    • Tsuchiya, Kaoru;
    • Nishiofuku, Hideyuki;
    • Yamakado, Koichiro;
    • Sone, Miyuki;
    • Ikeda, Masafumi;
    • Takehara, Tetsuo;
    • Hamano, Tetsutaro;
    • Kudo, Masatoshi
    Publication type:
    Article
    19

    Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13648-5
    By:
    • Kodama, Yoshihisa;
    • Ueshima, Kazuomi;
    • Moriguchi, Michihisa;
    • Inaba, Yoshitaka;
    • Yamashita, Tatsuya;
    • Iwamoto, Hideki;
    • Ueno, Makoto;
    • Ogasawara, Sadahisa;
    • Kuzuya, Teiji;
    • Kodama, Takahiro;
    • Sato, Yozo;
    • Tada, Toshifumi;
    • Tsuchiya, Kaoru;
    • Nishiofuku, Hideyuki;
    • Yamakado, Koichiro;
    • Sone, Miyuki;
    • Ikeda, Masafumi;
    • Takehara, Tetsuo;
    • Hamano, Tetsutaro;
    • Kudo, Masatoshi
    Publication type:
    Article
    20
    21
    22
    23

    The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84117-9
    By:
    • Kanzaki, Hiroaki;
    • Chiba, Tetsuhiro;
    • Ao, Junjie;
    • Koroki, Keisuke;
    • Kanayama, Kengo;
    • Maruta, Susumu;
    • Maeda, Takahiro;
    • Kusakabe, Yuko;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Saito, Tomoko;
    • Nakagawa, Ryo;
    • Ogasawara, Sadahisa;
    • Suzuki, Eiichiro;
    • Ooka, Yoshihiko;
    • Muroyama, Ryosuke;
    • Nakamoto, Shingo
    Publication type:
    Article
    24
    25

    Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor.

    Published in:
    Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 7, p. 1197, doi. 10.1111/jgh.12925
    By:
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Chiba, Tetsuhiro;
    • Saito, Tomoko;
    • Motoyama, Tenyu;
    • Suzuki, Eiichiro;
    • Ooka, Yoshihiko;
    • Tawada, Akinobu;
    • Kanda, Tatsuo;
    • Mikami, Shigeru;
    • Azemoto, Ryosaku;
    • Kaiho, Takashi;
    • Shinozaki, Masami;
    • Ohtsuka, Masayuki;
    • Miyazaki, Masaru;
    • Yokosuka, Osamu
    Publication type:
    Article
    26

    Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000.

    Published in:
    Digestion, 2023, v. 104, n. 4, p. 328, doi. 10.1159/000529816
    By:
    • Ohta, Yuki;
    • Taida, Takashi;
    • Kato, Jun;
    • Ogasawara, Sadahisa;
    • Oyama, Yuhei;
    • Mamiya, Yukiyo;
    • Nakazawa, Hayato;
    • Horio, Ryosuke;
    • Goto, Chihiro;
    • Takahashi, Satsuki;
    • Kurosugi, Akane;
    • Sonoda, Michiko;
    • Shiratori, Wataru;
    • Kaneko, Tatsuya;
    • Yokoyama, Yuya;
    • Akizue, Naoki;
    • Ishigami, Hideaki;
    • Koseki, Hirotaka;
    • Okimoto, Kenichiro;
    • Saito, Keiko
    Publication type:
    Article
    27
    28
    29
    30

    Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus.

    Published in:
    International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 12015, doi. 10.3390/ijms231912015
    By:
    • Ma, Yaojia;
    • Nakamoto, Shingo;
    • Ao, Junjie;
    • Qiang, Na;
    • Kogure, Tadayoshi;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Iwanaga, Terunao;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Nakagawa, Ryo;
    • Ogasawara, Sadahisa;
    • Muroyama, Ryosuke
    Publication type:
    Article
    31

    Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors.

    Published in:
    International Journal of Molecular Sciences, 2017, v. 18, n. 5, p. 906, doi. 10.3390/ijms18050906
    By:
    • Tatsuo Kanda;
    • Shin Yasui;
    • Masato Nakamura;
    • Eiichiro Suzuki;
    • Makoto Arai;
    • Yoshihiko Ooka;
    • Sadahisa Ogasawara;
    • Tetsuhiro Chiba;
    • Tomoko Saito;
    • Yuki Haga;
    • Koji Takahashi;
    • Reina Sasaki;
    • Shuang Wu;
    • Shingo Nakamoto;
    • Akinobu Tawada;
    • Hitoshi Maruyama;
    • Fumio Imazeki;
    • Naoya Kato;
    • Osamu Yokosuka
    Publication type:
    Article
    32
    33

    Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma.

    Published in:
    Cancers, 2021, v. 13, n. 9, p. 2247, doi. 10.3390/cancers13092247
    By:
    • Saeki, Issei;
    • Yamasaki, Takahiro;
    • Yamauchi, Yurika;
    • Takami, Taro;
    • Kawaoka, Tomokazu;
    • Uchikawa, Shinsuke;
    • Hiramatsu, Akira;
    • Aikata, Hiroshi;
    • Kawano, Reo;
    • Kobayashi, Kazufumi;
    • Kondo, Takayuki;
    • Ogasawara, Sadahisa;
    • Chiba, Tetsuhiro;
    • Chayama, Kazuaki;
    • Kato, Naoya;
    • Sakaida, Isao;
    • Vitale, Alessandro;
    • Lai, Quirino;
    • Geller, David A.
    Publication type:
    Article
    34

    Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 4, p. 590, doi. 10.1002/cncr.34559
    By:
    • Nakagawa, Miyuki;
    • Inoue, Masanori;
    • Ogasawara, Sadahisa;
    • Maruta, Susumu;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Kikuchi, Yasuharu;
    • Kogure, Tadayoshi;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Fujiwara, Kisako;
    • Iwanaga, Terunao;
    • Fujita, Naoto;
    • Sakuma, Takafumi;
    • Kojima, Ryuta
    Publication type:
    Article
    35

    Health‐related quality‐of‐life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE‐240.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 6, p. 865, doi. 10.1002/cncr.33317
    By:
    • Ryoo, Baek‐Yeol;
    • Merle, Philippe;
    • Kulkarni, Amit S.;
    • Cheng, Ann‐Lii;
    • Bouattour, Mohamed;
    • Lim, Ho Yeong;
    • Breder, Valeriy;
    • Edeline, Julien;
    • Chao, Yee;
    • Ogasawara, Sadahisa;
    • Yau, Thomas;
    • Garrido, Marcelo;
    • Chan, Stephen L.;
    • Daniele, Bruno;
    • Norquist, Josephine M.;
    • Chen, Erluo;
    • Siegel, Abby B.;
    • Zhu, Andrew X.;
    • Finn, Richard S.;
    • Kudo, Masatoshi
    Publication type:
    Article
    36

    Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.

    Published in:
    CardioVascular & Interventional Radiology, 2022, v. 45, n. 4, p. 405, doi. 10.1007/s00270-021-03031-9
    By:
    • Llovet, Josep M.;
    • Vogel, Arndt;
    • Madoff, David C.;
    • Finn, Richard S.;
    • Ogasawara, Sadahisa;
    • Ren, Zhenggang;
    • Mody, Kalgi;
    • Li, Jerry J.;
    • Siegel, Abby B.;
    • Dubrovsky, Leonid;
    • Kudo, Masatoshi
    Publication type:
    Article
    37

    Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment.

    Published in:
    JGH Open, 2021, v. 5, n. 11, p. 1266, doi. 10.1002/jgh3.12660
    By:
    • Mukai, Shohei;
    • Kanzaki, Hiroaki;
    • Ogasawara, Sadahisa;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Unozawa, Hidemi;
    • Iwanaga, Terunao;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Saito, Tomoko;
    • Nakagawa, Ryo;
    • Suzuki, Eiichiro
    Publication type:
    Article
    38

    Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma.

    Published in:
    JGH Open, 2021, v. 5, n. 2, p. 273, doi. 10.1002/jgh3.12483
    By:
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Inoue, Masanori;
    • Wakamatsu, Toru;
    • Yokoyama, Masayuki;
    • Maruta, Susumu;
    • Unozawa, Hidemi;
    • Iwanaga, Terunao;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Maeda, Takahiro;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Saito, Tomoko;
    • Motoyama, Tenyu
    Publication type:
    Article
    39

    Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.

    Published in:
    Journal of Gastroenterology, 2024, v. 59, n. 6, p. 515, doi. 10.1007/s00535-024-02097-9
    By:
    • Fujiwara, Kisako;
    • Kondo, Takayuki;
    • Fujimoto, Kentaro;
    • Yumita, Sae;
    • Ogawa, Keita;
    • Ishino, Takamasa;
    • Nakagawa, Miyuki;
    • Iwanaga, Terunao;
    • Tsuchiya, Satoshi;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Koizumi, Jun
    Publication type:
    Article
    40

    Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents.

    Published in:
    Journal of Gastroenterology, 2022, v. 57, n. 2, p. 90, doi. 10.1007/s00535-021-01837-5
    By:
    • Seko, Yuya;
    • Moriguchi, Michihisa;
    • Takahashi, Aya;
    • Yamaguchi, Kanji;
    • Umemura, Atsushi;
    • Okuda, Keiichiro;
    • Kataoka, Seita;
    • Unozawa, Hidemi;
    • Kobayashi, Kazufumi;
    • Ogasawara, Sadahisa;
    • Sato, Rui;
    • Tsuchiya, Satoshi;
    • Watanabe, Shunji;
    • Morimoto, Naoki;
    • Iwai, Kenji;
    • Aramaki, Takeshi;
    • Kato, Naoya;
    • Itoh, Yoshito
    Publication type:
    Article
    41
    42
    43

    Simultaneous Resection of Disseminated Hepatocellular Carcinoma and Colon Cancer.

    Published in:
    Case Reports in Gastroenterology, 2013, v. 7, n. 1, p. 37, doi. 10.1159/000346925
    By:
    • Haga, Yuki;
    • Chiba, Tetsuhiro;
    • Ohira, Gaku;
    • Kanai, Fumihiko;
    • Yokota, Hajime;
    • Motoyama, Tenyu;
    • Ogasawara, Sadahisa;
    • Suzuki, Eiichiro;
    • Ooka, Yoshihiko;
    • Tawada, Akinobu;
    • Miyauchi, Hideaki;
    • Matubara, Hisahiro;
    • Yokosuka, Osamu
    Publication type:
    Article
    44

    Successful Resection of Intracranial Metastasis of Hepatocellular Carcinoma.

    Published in:
    Case Reports in Gastroenterology, 2013, v. 7, n. 1, p. 182, doi. 10.1159/000350673
    By:
    • Okimoto, Kenichiro;
    • Ogasawara, Sadahisa;
    • Chiba, Tetsuhiro;
    • Kanai, Fumihiko;
    • Yokota, Hajime;
    • Motoyama, Tenyu;
    • Suzuki, Eiichiro;
    • Ooka, Yoshihiko;
    • Tawada, Akinobu;
    • Iwadate, Yasuo;
    • Saeki, Naokatsu;
    • Yokosuka, Osamu
    Publication type:
    Article
    45
    46

    Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).

    Published in:
    Investigational New Drugs, 2024, v. 42, n. 4, p. 394, doi. 10.1007/s10637-024-01441-3
    By:
    • Kobayashi, Kazufumi;
    • Ogasawara, Sadahisa;
    • Itobayashi, Ei;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Nakamura, Kazuyoshi;
    • Moriguchi, Michihisa;
    • Watanabe, Shunji;
    • Ikeda, Masafumi;
    • Kuroda, Hidekatsu;
    • Kawaoka, Tomokazu;
    • Hiraoka, Atsushi;
    • Yasui, Yutaka;
    • Kuzuya, Teiji;
    • Sato, Rui;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Nakamura, Masato;
    • Kiyono, Soichiro
    Publication type:
    Article
    47

    Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan.

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 1, p. 172, doi. 10.1007/s10637-019-00801-8
    By:
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Itokawa, Norio;
    • Inoue, Masanori;
    • Okabe, Shinichiro;
    • Seki, Atsuyoshi;
    • Haga, Yuki;
    • Obu, Masamichi;
    • Atsukawa, Masanori;
    • Itobayashi, Ei;
    • Mizumoto, Hideaki;
    • Sugiura, Nobuyuki;
    • Azemoto, Ryosaku;
    • Kanayama, Kengo;
    • Kanzaki, Hiroaki;
    • Maruta, Susumu;
    • Maeda, Takahiro;
    • Kusakabe, Yuko;
    • Yokoyama, Masayuki;
    • Kobayashi, Kazufumi
    Publication type:
    Article
    48

    Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment.

    Published in:
    Investigational New Drugs, 2018, v. 36, n. 2, p. 332, doi. 10.1007/s10637-017-0507-3
    By:
    • Sadahisa Ogasawara;
    • Tetsuhiro Chiba;
    • Yoshihiko Ooka;
    • Eiichiro Suzuki;
    • Takahiro Maeda;
    • Masayuki Yokoyama;
    • Toru Wakamatsu;
    • Masanori Inoue;
    • Tomoko Saito;
    • Kazufumi Kobayashi;
    • Soichiro Kiyono;
    • Masato Nakamura;
    • Shingo Nakamoto;
    • Shin Yasui;
    • Akinobu Tawada;
    • Makoto Arai;
    • Tatsuo Kanda;
    • Hitoshi Maruyama;
    • Osamu Yokosuka;
    • Naoya Kato
    Publication type:
    Article
    49
    50